Dergiler / Medicine Science / 2013 / Cilt: 2 Sayı: 1

VDBP Gene Polymorphism in COPD

Sayfa
403–413
Yayın Tarihi
2013-03-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our results do not show any evidence that indicate a protective or susceptibility effect of VDBP 2 and 1F alleles in progression of COPD, respectively but results indicate that having the 1S-1S genotype may be associated with the etiology of COPD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Chronic obstructive pulmonary disease (COPD) is a disease which genetic and environmental factors play an important role in COPD development.
📊
Temel Bulgular & Veri:We studied VDBP genotypes in 75 COPD patients, 36 smoker healthy subjects and 19 non-smoker healthy subjects with PCR-RFLP method to analyze the association between VDBP and COPD.
💡
Sonuç & Katkı:Our results do not show any evidence that indicate a protective or susceptibility effect of VDBP 2 and 1F alleles in progression of COPD, respectively but results indicate that having the 1S-1S genotype may be associated with the etiology of COPD.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:COPD · VDBP · genetic polymorphism

Abstract

Chronic obstructive pulmonary disease (COPD) is a disease which genetic and environmental factors play an important role in COPD development. VDBP (Vitamin D Binding Protein ) gene might be responsible for COPD development. The purpose of this study to investigate the possible effect of VDBP on progression of COPD. We studied VDBP genotypes in 75 COPD patients, 36 smoker healthy subjects and 19 non-smoker healthy subjects with PCR-RFLP method to analyze the association between VDBP and COPD. In our study, the most frequently seen genotype was 1S-2 with a frequency of 32% in COPD group; and 1F-1S genotype with a frequency of 33.3% in smoker healthy group. There was no significant difference between these genotypes. In our study groups, we did not find any 2-2 genotype in non-smoker healthy subject group while it has been found 4% and 8% in COPD and healthy smoker subject groups, respectively. Although we did not find any significant difference for protective effect of the 2 allele on the disease or susceptibility of 1F allele to COPD formation in COPD patients and smoker healthy subjects (p: 0.346, p: 0.249, respectively), the only significant difference was between the patient and the healthy non-smoker groups with 1S-1S genotype (p=0.032). Our results do not show any evidence that indicate a protective or susceptibility effect of VDBP 2 and 1F alleles in progression of COPD, respectively but results indicate that having the 1S-1S genotype may be associated with the etiology of COPD.

🔖

Bu Makaleye Atıf Yap

Soyyigit, S., Baykara, O., BUYRU, N., ERK, M., SOYYİGİT, S., BAYKARA, O., BUYRU, N., ERK, M. (2013). VDBP Gene Polymorphism in COPD. Medicine Science, Cilt: 2 Sayı: 1, 403–413. https://ajindex.com/articles/1003324

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166(5):675-9.
  2. Celli BR, Macnee W, Agusti A, Anzueto A, Berg B, Buist AS, Calcerley PMA, Chavannes N, Dillard T. Standarts for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23:932-46.
  3. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001;17:982-94.
  4. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am. 1996;80:501-22.
  5. Williams C, Clymer M. A practical treatise on the disease of the respiratory organs.:Including disease of the larynx. Trachea, Lungs and Pleura. Philadelphia: Lea and Blanchard;1845. Tager I, Tishler PV, Rosner B, Speizer FE, Litt M. Studies of the familial aggregation of chronic bronchititis and obstructive airways disease. Int J Epidemiol 1978;7:55-62.
  6. Khoury MJ, Beaty TH, Newill CA. Genetic environmental interactions in chronic airways obstruction. Int J Epidemiol 1986;15:55-62.
  7. Kueppers F, Miller RD, Gordon H, Offord K, Hepper NG. Familial prevalance of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977;10:1380-91.
  8. Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE. Assesment of genetic and nongenetic influences on pulmonary function. Am Rev Respir Dis. 1987, 135:217-22.
  9. Redline S, Tishler PV, Rosner B, Lewirrer FI, Vandenburg M, Weiss ST, Speizer FE. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989;129:827-36.
  10. McClern GE, Svarttergen M, Pedersen NL. Genetic and environmental influences on pulmonary function in aging Swedish twins. J Gerentol 1994;49:264-8. Barnes PJ. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999;54:245-52.
  11. Sandford AJ, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Clin Chest Med 2000;21:633-43.
  12. Yamamoto N, Homma S. Vitamin D binding protein (group-specific component) is a precursor for macrophage activating signal factor from lysophosphatidilcoline-treated lymphocytes. Proc Natl Aca Sci USA 1991;88:8539-43.
  13. Cooke NE, Willard IF, David V, George DL. Direct regional assassment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorp